Literature DB >> 2942870

[Synergism or antagonism in combinations of beta-lactam antibiotics].

M L Joly-Guillou, E Bergogne-Berezin.   

Abstract

Several examples of antagonistic combinations between cefoxitin and other beta-lactam antibiotics have been reported in the literature. This phenomenon may occur especially with Enterobacter spp, Pseudomonas aeruginosa, Citrobacter spp, and Serratia marcescens. In these species, induction of chromosomally mediated beta-lactamases by certain potent inducers, such as cefoxitin, has been suggested as the main mechanism of antagonism. These in vitro interactions may have clinical relevance; however, although studies in animal models have shown a few examples of in vivo antagonism, the actual clinical significance of interactions between beta-lactam antibiotics requires further thorough and controlled clinical studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942870

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

Review 1.  Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.

Authors:  Andrew V Anzalone; Luke W Koblan; David R Liu
Journal:  Nat Biotechnol       Date:  2020-06-22       Impact factor: 54.908

2.  Harnessing type I CRISPR-Cas systems for genome engineering in human cells.

Authors:  Peter Cameron; Mary M Coons; Sanne E Klompe; Alexandra M Lied; Stephen C Smith; Bastien Vidal; Paul D Donohoue; Tomer Rotstein; Bryan W Kohrs; David B Nyer; Rachel Kennedy; Lynda M Banh; Carolyn Williams; Mckenzi S Toh; Matthew J Irby; Leslie S Edwards; Chun-Han Lin; Arthur L G Owen; Tim Künne; John van der Oost; Stan J J Brouns; Euan M Slorach; Chris K Fuller; Scott Gradia; Steven B Kanner; Andrew P May; Samuel H Sternberg
Journal:  Nat Biotechnol       Date:  2019-11-18       Impact factor: 54.908

3.  Target-specific mutations efficiency at multiple loci of CRISPR/Cas9 system using one sgRNA in soybean.

Authors:  Ling Zhang; Yingzhe Wang; Tong Li; Hongmei Qiu; Zhengjun Xia; Yingshan Dong
Journal:  Transgenic Res       Date:  2021-01-02       Impact factor: 2.788

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.